CXCR4 Antagonist AMD3100 Accelerates Impaired Wound Healing in Diabetic Mice

The antagonism of CXC-chemokine receptor 4 (CXCR4) with AMD3100 improves cardiac performance after myocardial infarction by augmenting the recruitment of endothelial progenitor cells (EPCs) from the bone marrow to the regenerating vasculature. We investigated whether AMD3100 may accelerate diabetes-...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Nishimura, Yukihide, Ii, Masaaki, Qin, Gangjian, Hamada, Hiromichi, Asai, Jun, Takenaka, Hideya, Sekiguchi, Haruki, Renault, Marie-Ange, Jujo, Kentaro, Katoh, Norito, Kishimoto, Saburo, Ito, Aiko, Kamide, Christine, Kenny, John, Millay, Meredith, Misener, Sol, Thorne, Tina, Losordo, Douglas W.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3276738/
https://ncbi.nlm.nih.gov/pubmed/22048734
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/jid.2011.356
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados